Blockchain Registration Transaction Record
Soligenix CEO Discusses Robust Pipeline and Strategic Milestones on BioMedWire Podcast
Soligenix CEO Dr. Christopher Schaber discusses the company's rare disease therapeutics focus, ongoing clinical trials, and innovative vaccine development on IBN's BioMedWire Podcast. Learn more about Soligenix's robust pipeline and government funding support.

This news matters as it highlights Soligenix's innovative approach to rare disease therapeutics and vaccine development, showcasing the company's potential to address significant unmet medical needs. The discussion of near-term milestones and government funding demonstrates Soligenix's commitment to advancing healthcare solutions and its strategic positioning in the biopharmaceutical industry.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xcb4f61f2088b299db86c11b15a8856de7f6035158c0ee1ac60d49fed2e793e24 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | joltwBbt-0641f1e76940edf5d4b7e106d2d747cc |